4.7 Article

Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022

Journal

JOURNAL OF INFECTIOUS DISEASES
Volume 227, Issue 8, Pages 961-969

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jiac458

Keywords

severe COVID-19 outcomes; COVID-19 vaccination; ICU admission; Delta period; Omicron period

Ask authors/readers for more resources

This study assessed the impact of COVID-19 vaccination on illness severity among hospitalized adults with COVID-19. The findings showed that vaccination with 2 or 3 mRNA vaccine doses was associated with reduced ICU admission and in-hospital death, as well as shorter hospital stays.
Background We assessed coronavirus disease 2019 (COVID-19) vaccination impact on illness severity among adults hospitalized with COVID-19, August 2021-March 2022. Methods We evaluated differences in intensive care unit (ICU) admission, in-hospital death, and length of stay among vaccinated (2 or 3 mRNA vaccine doses) versus unvaccinated patients aged >= 18 years hospitalized for >= 24 hours with COVID-19-like illness and positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) molecular testing. We calculated odds ratios (ORs) for ICU admission and death and subdistribution hazard ratios (SHR) for time to hospital discharge adjusted for age, geographic region, calendar time, and local virus circulation. Results We included 27 149 SARS-CoV-2-positive hospitalizations. During both Delta- and Omicron-predominant periods, protection against ICU admission was strongest among 3-dose vaccinees compared with unvaccinated patients (Delta OR, 0.52 [95% CI, .28-.96]; Omicron OR, 0.69 [95% CI, .54-.87]). During both periods, risk of in-hospital death was lower among vaccinated compared with unvaccinated patients but ORs overlapped across vaccination strata. We observed SHR >1 across all vaccination strata in both periods indicating faster discharge for vaccinated patients. Conclusions COVID-19 vaccination was associated with lower rates of ICU admission and in-hospital death in both Delta and Omicron periods compared with being unvaccinated. COVID-19 vaccination was associated with lower rates of ICU admission and in-hospital mortality during both Delta and Omicron predominance compared with being unvaccinated. COVID-19 vaccines attenuate disease severity in patients hospitalized with symptomatic SARS-CoV-2 infection.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available